Correlation Between Soleno Therapeutics and Lipocine

Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Soleno Therapeutics and Lipocine, you can compare the effects of market volatilities on Soleno Therapeutics and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Lipocine.

Diversification Opportunities for Soleno Therapeutics and Lipocine

-0.09

Correlation Coefficient

Soleno Therapeutics  Lipocine

Good diversification

The 3 months correlation between Soleno and Lipocine is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Lipocine go up and down completely randomly.

Pair Corralation between Soleno Therapeutics and Lipocine

Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 0.78 times more return on investment than Lipocine. However, Soleno Therapeutics is 1.28 times less risky than Lipocine. It trades about 0.05 of its potential returns per unit of risk. Lipocine is currently generating about -0.1 per unit of risk. If you would invest  4,495  in Soleno Therapeutics on December 21, 2024 and sell it today you would earn a total of  299.00  from holding Soleno Therapeutics or generate 6.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Soleno Therapeutics  vs.  Lipocine

Soleno Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Lipocine

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lipocine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Soleno Therapeutics and Lipocine

The main advantage of trading using opposite Soleno Therapeutics and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.

The idea behind Soleno Therapeutics and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.